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Cardiovascular (CV) diseases are burdened by high mortality and morbidity, being re-
sponsible for half of the deaths in Europe. Although hypertension is recognized as
the most important CV risk factor, hypertension awareness, and blood pressure (BP)
control are still unsatisfactory. In 2017 and 2018, respectively >10 000 and >5000
individuals took part in the May Measurement Month (MMM) campaign in Italy, of
whom 30.6% and 26.3% were found to have high BP, respectively. To raise public
awareness on the importance of hypertension and to collect BP data on a nation-
wide scale in Italy. In the frame of the MMM campaign, an opportunistic cross-sec-
tional survey of volunteers aged 18 years was carried out in May 2019. BP measure-
ment, the definition of hypertension, and statistical analysis followed the standard
MMM protocol. Screening was conducted in multiple sites by health personnel.
Among the 10 182 people screened (females: 52.3%, mean age 586 16years) mean
BP was 127/78mmHg, and 3171 (31.1%) participants had arterial hypertension, of
whom 62.1% were aware of being hypertensive. Diabetes, body mass index
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>25 kg/m2 were associated with higher BP and previous myocardial infarction with
lower BP. For the third consecutive year we collected a nation-wide snapshot of BP
control in a large sample of individuals. The high participation, with some yearly
fluctuations likely due to the limitations of the sampling technique, confirms the
power of this kind of health campaign in reaching a significant number of people to
raise awareness on health topics.
Introduction
Cardiovascular (CV) diseases (CVDs) are responsible for
more than half of all deaths across Europe.1 Due to a com-
bination of modifiable and non-modifiable factors, includ-
ing unhealthy lifestyle and improved survival after acute
events, their prevalence is on the rise.1
In 2016, the Italian Agency of Statistics (ISTAT) reported
a yearly incidence of 367 deaths due to CVDs per 100 000
inhabitants, corresponding to a total of approximately
220 200 deaths.2
The effectiveness of global CV risk reduction in prevent-
ing events is universally accepted3,4 and up to 80% of pre-
mature heart disease and stroke events are considered
preventable.5,6 Arterial hypertension represents the most
important independent risk factor for CVDs,7 with a
reported prevalence in Italy of about 30% in the adult popu-
lation,8 with target blood pressure (BP) values reportedly
reached in less than 50% of known hypertensives.9 The
Italian Society of Hypertension (SIIA) has been active over
many years in raising awareness on this issue, taking part
each year for more than a decade in World Hypertension
Day, promoted by the World Hypertension League. Taking
part in the May Measurement Month (MMM) initiative10–12
was just the natural step forward, to reach as many people
as possible and involve them in the fight against hyperten-
sion. In 2017 and 2018, thanks to the invaluable contribu-
tion of more than 300 investigators affiliated to the SIIA
(see Supplementary material online, Appendix 1) and of
the Italian Red Cross, we were able to reach >10 000 and
>5000 people10,13 respectively, an effort repeated also in
year 2019.
Methods
MMM19 activities in Italy were conducted according to
the same protocol as in previous years, with the support
of the SIIA. Informed consent was obtained for each par-
ticipant onsite. No personal information was requested,
as all forms were anonymous. During the month of May
2019, 250 sites in Italy operated for a different number
of days (from 1 to 5 days depending on the site), inter-
viewing and measuring the BP of individuals aged 18years
and over who decided to stop by. Three seated BP meas-
urements were recorded with an automated validated
device (Omron M3 Comfort, HEM-7134-E, Omron Health
Care; Japan) A total estimated number of 200 staff vol-
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Figure 1 Blood pressure values by age and gender in the screened Italian population. Difference in mean blood pressure according to age and sex from
linear regression model, excluding individuals receiving treatment.
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methods have already been described13 Hypertension
was defined as BP 140 and/or 90mmHg based on the
mean of the second and third BP readings or those on an-
tihypertensive medication. Data were analysed by the
MMM team with multiple imputation of missing BP read-
ings according to a standard analysis plan.12
Results
Our sample consisted of 10 182 participants (females:
52.3%), with a mean (standard deviation) age of 58 (16)
years. The absolute number of participants per age group
increased by each decade after 39years of age, reaching
its maximum in age group >70 years (2629 subjects, 25.8%
of the whole cohort).
Active smoking was reported by 1919 (18.8%), diabetes
by 870 (8.5%), previous myocardial infarction by 714
(7.0%), and previous cerebrovascular accident by 351
(3.4%). Mean body mass index was 25.56 4.5 kg/m2, with
48.9% of subjects being of normal weight or underweight
and 48.9% overweight or obese.
The mean BP (mean of reading 2 and 3) was 127/
78mmHg, and after imputation, 3171 (31.1%) participants
were found to have hypertension. Both systolic and dia-
stolic BP were lower in females over an age range between
18 and 80years (Figure 1).
Of all 3171 participants with hypertension, 62.1% were
aware of their condition and 16.2% were on antihyperten-
sive medication. Of 513 participants on antihypertensive
medication, 45.8% had their BP controlled; while of all
3171 participants with hypertension, 7.4% had their BP
controlled.
Known hypertension, hypertension medication use, dia-
betes, and overweight/obesity were associated with higher
BP values (P < 0.0001). Those with a previous myocardial
infarction and those who were underweight (compared to
those of a healthy weight) had lower mean BP values.
(Figures 2 and 3).
Discussion
Our data, obtained through a cross-sectional nation-wide
survey, provides a contemporary update on BP values in a
sample of the Italian population, adhering to the MMM19
initiative. The percentage of screened individuals found to
be hypertensive (31.2%), is aligned with that reported dur-
ing the MMM 2017 campaign (30.8% out of >10 000
Figure 2 Mean blood pressure values changes in different cardiovascu-
lar risk factors. Difference in mean blood pressure in those with each co-
morbidity compared to those without from linear regression models
adjusted for age, sex, and antihypertensive medication (antihypertensive
medication adjusted for age and sex alone).
Figure 3 Mean blood pressure values changes by body weight. Difference in mean blood pressure in each body-mass index category compared to healthy
weight from linear regression models, adjusted for age, sex, and antihypertensive medication.
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individuals),13 but lower than observed in 2015 during the
World Hypertension Day campaign (36% out of 8657 individ-
uals).9 The reported average BP values decreased slightly
from 2015 (133/80mmHg)9 to 2017 (130/78mmHg)13 to
2018 (127/77mmHg) and were then essentially stable in
2019 (127/78mmHg). Interpretation of these data, espe-
cially in terms of comparability from one year to the other,
should take into account a number of methodological limi-
tations, typical of ‘street epidemiology’ (such as sampling
bias, incomplete sample characterization, environmental
factors unaccounted for, lack of specific cut-off values for
BP measured in such circumstances, etc.). These limita-
tions may likely explain the lower rate of individuals with
high BP observed in 2018 (26%) compared to all the other
years. On the other hand, the trend in reduction of average
BP levels, irrespective of hypertension prevalence, seems
to have been confirmed over the years. Indeed, over the
years significant and continuing efforts have been made by
SIIA to raise awareness of hypertension as a risk factor,14 to
increase its early diagnosis and improve BP control. Other
survey findings are generally consistent with those of previ-
ous campaigns and are in line with available evidence, in-
cluding the relationships between body weight and BP,
increased prevalence of high BP values in diabetic patients,
differences between females’ and males’ BP, which nar-
rows as age increases.15 Lower BP values in patients with
previous myocardial infarction are likely due to larger use
of CV drugs in secondary prevention.
By joining the MMM campaign, we have been able to
spread awareness on BP levels and hypertension-related
issues among a significant number of people, with the final
goal of improving BP control and reducing CVmorbidity and
mortality.
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